Despite the availability of vaccines, influenza is a significant public health problem, which emphasizes the need for development of additional strategies to enhance host defense against influenza. Wolfberry, or goji berry, long used as a medicinal food in China, has recently been shown to improve immune response in mice. Because immune response plays a key role in the body's defense against pathogens, we hypothesized that wolfberry may increase host resistance to influenza infection by enhancing immune response. To test this hypothesis, we fed adult mice (4 mo old) a milk-based preparation of wolfberry called Lacto-Wolfberry (LWB) for 4 wk and then infected them with influenza A/Puerto Rico/8/34 (H1N1) while continuing the same experimental diets. Viral titer, lung pathology, and immune response were determined at different time points postinfection. LWB supplementation prevented infection-induced weight loss and reduced lung pathology on days 6 and 9 postinfection (P , 0.05). LWB-fed mice showed overall, significantly higher concanavalin A-induced IL-2 production (P , 0.05). Furthermore, we found positive correlations between weight loss and lung viral titer, pathology score, TNFa, and IL-6 production as well as negative correlations with T cell proliferation and IL-2 production (all at P , 0.05 or smaller). These results indicate that LWB supplementation can attenuate symptoms and pathology of influenza infection by decreasing inflammatory cytokines in lungs while enhancing systemic T cell-mediated function as measured by their ability to produce IL-2. J. Nutr.
Introduction
Despite the availability of vaccines and antiviral agents, influenza virus continues to be a major cause of morbidity and mortality worldwide. Influenza virus causes 3-5 million cases of severe illness and 250,000-500,000 deaths annually worldwide (1) . New viral variants emerge constantly and are responsible for yearly epidemics. Antigenic shifts can produce new virus strains to which most people have no immunity, resulting in pandemics. With the increasing threat of influenza outbreak, it is imperative to develop a preventive strategy to enhance human host resistance to influenza infection.
Immune functions, particularly innate and T cell-mediated immune responses, play a key role in preventing and controlling microbial infection. Upon infection with influenza, a coordinated immune response of both innate and adaptive mechanisms results in accumulation of immune cells and secretion of immunomodulatory molecules to combat the virus. However, there are limited strategies available to efficiently modulate host immune response. Nutritional intervention that involves optimizing the intake of essential nutrients and using promising functional foods has been proposed as an effective approach to modulate immune cell functions (2) (3) (4) (5) (6) .
Wolfberry (goji berry), the fruit of Lycium barbarum (Lycii fructus in the West; Gou Qi Zi and Kei Tze in Asia), is a sweet red berry that has been used traditionally as a medicinal food in China (7) . Studies have suggested that Wolfberry may have antiaging, anticancer, health-promoting, and immune-boosting properties (8) (9) (10) (11) (12) . It is also considered to be one of the richest natural sources of zeaxanthin, a non-provitamin A carotenoid shown to protect the eyes (13) and to enhance immune response (14) (15) (16) (17) . Wolfberry has been shown to have a high level of antioxidant activity (11) . A specially formulated wolfberry product called Lacto-Wolfberry (LWB), 8 which is made by homogenizing wolfberries in skimmed milk, has been shown to greatly enhance bioavailability of zeaxanthin (18) . Recent studies have shown that dietary supplementation with wolfberry can enhance immune responses in both animals and humans (19, 20) . Furthermore, LWB supplementation (13.7 g/d) was reported to increase specific antibody response to the influenza vaccine in healthy free-living elderly individuals (21) . Although these results are encouraging, their clinical relevance needs to be determined. Thus, we conducted the current study using a mouse model of influenza infection to determine the effect of dietary LWB supplementation on host immune response and resistance to influenza infection.
Materials and Methods
Animals and diet. Specific pathogen-free adult (4 mo old) male C57BL/ 6JNIA mice were purchased from the National Institute on Aging colonies at Harlan Sprague Dawley and randomly assigned to LWB or control groups after 7 d of acclimatation to the facility. Mice were individually housed in cages at a constant temperature (238C) with a 12/ 12-h light/dark cycle and allowed access to food and water ad libitum. Mice were fed the AIN-93M diet (22) containing none (control) or 5% LWB for 4 wk before infection; they then continued consuming the same diets during the infection period (up to an additional 9 d). LWB, which was provided by Nestlé Research Center (Lausanne, Switzerland), contained 530 mg/g of wolfberry fruit, 290 mg/g of skimmed milk, and 180 mg/g of maltodextrin. Mice were checked daily for eating, drinking, and locomotion activity, and they were weighed weekly during the feeding period and before they were killed. At the end of the feeding period, mice were killed at specified times (days) postinfection (p.i.) (0, 2, 6, and 9 d) by CO 2 asphyxiation and exsanguination. All conditions and handling of the animals were approved by the Animal Care and Use Committee of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and were conducted according to the NIH Guidelines for the Care and Use of Laboratory Animals.
Virus and infection. Influenza A/Puerto Rico/8/34 was provided by Dr. Barry Ritz, Drexel University (Philadelphia, PA). This H1N1 strain of mouse-adapted influenza A was propagated in specific pathogen-free eggs (B&E Eggs), and cell-free supernatants were stored at 2708C until use. After 4 wk of LWB dietary supplementation, mice were anesthetized with an intramuscular injection of a ketamine (60 mg/kg)/xylazine (1.25 mg/kg) solution, and then each mouse was infected intranasally with 50 hemagglutinin units of influenza A/Puerto Rico/8/34 virus diluted in 0.05 mL PBS. After infection, the mice continued consuming their experimental diets. They were weighed daily and killed at d 0, 2, 6, or 9 p.i.
Pathology. One lobe of the left lung was collected on d 0, 6, and 9 p.i., perfused with 10% formaldehyde, paraffin embedded, cut into 6-mm sections, and stained with hematoxylin and eosin. Grading was performed semiquantitatively by an outside pathologist (Dr. Roderick Bronson, Harvard Medical School) to assess the relative degree of inflammatory infiltration as previously described (23) .
Lung and spleen cell isolation. The whole lung, except for one lobe of left lung used for pathologic analysis, was weighed, minced, and incubated at 378C for 1.5 h in RPMI 1640 medium (Biowhittaker) containing 5% FBS, 3 g/L collagenase A, and 8 3 10 4 unit/L DNase (Roche). Digested lung samples were passed through a 30-mm cell strainer and centrifuged at 500 3 g for 5 min. Supernatants were separated into aliquots and stored at 2708C for subsequent analysis of viral titers and cytokines. The cell suspensions were layered on Histopaque-1083 (Sigma) and subjected to density gradient centrifugation at 1400 3 g for 20 min. Single-cell suspensions from spleen were prepared as previously described (24) . Cells from each tissue were resuspended at appropriate densities for use in subsequent assays. All of the cell culture work was conducted at 378C, in a 5% CO 2 atmosphere, and at 95% humidity.
Lung viral titer. Virus titer in supernatant was measured by using a Madin-Darby canine kidney assay as previously described (25) . Briefly, serially diluted lung supernatants were used to infect Madin-Darby canine kidney cells (American Type Culture Collection), and after incubation 0.5% fresh chicken RBC suspension (Lampire Biological Laboratories) was added. Viral titers were then determined on the basis of the presence or absence of hemagglutination. The TCID50 (50% tissue culture infectious dose) was calculated by using the method of Reed and Muench (26) .
NK cell cytotoxicity. NK cell activity was assessed by using radioisotope 51 Cr release assay as previously described (27) . YAC-1 cells (American Type Culture Collection) were used as target cells, and radioactivity as counts per minute (cpm) released into medium was measured. NK cell activity was expressed as specific lysis (%): (sample cpm -spontaneous cpm)/(maximum cpm -spontaneous cpm) 3 100. Cytokine production. For IL-2, IFNg, IL-4, and IL-10 production, splenocytes were cultured at 5 3 10 6 cells/well in the presence of con A (5 mg/L) or immobilized anti-CD3 (5 mg/L)/soluble anti-CD28 (1 mg/L) in 24-well culture plates (Becton Dickinson Labware) for 48 h. For IL-6, TNFa, and IL-1b production, splenocytes were stimulated with LPS (1 mg/L; Sigma) for 24 h. Cell-free supernatants were collected and stored at 2708C. All of the cytokines were measured by using ELISA following the standard protocols from the manufacturers. Reagents for IL-1b were from R&D Systems and reagents for all other cytokines were from BD PharMingen.
Flow cytometry and immunophenotyping. The percentages of major component cell types in spleen were determined by using fluorescenceactivated cell sorting analysis. Splenocytes (1 3 10 6 /sample) were stained with the following anti-mouse antibodies: fluorescein isothiocyanateconjugated anti-CD3 (T cells), allophycocyanin-conjugated anti-CD4 (T helper cells), allophycocyanin-conjugated anti-CD8 (T suppressor/ cytotoxic cells), phycoerythrin-conjugated anti-CD44 (low as naive and high as memory T cells when combined with the T cell markers). All of the antibodies were from BD PharMingen. Stained cells were analyzed on a FACSCalibur (BD Biosciences), and the results were analyzed by using the software Summit 4.0 (DakoCytomation).
Glutathione measurement. A piece of liver weighing ;100 mg was homogenized in 1 mL PBS containing 0.1% butylated hydroxytoluene on ice by using a Tissue Tearor (Biospec Products). One-half milliter of ice-cold perchloric acid (1 mol/L) was added and mixed with the same volume of homogenized tissue. After centrifugation at 1500 3 g for 15 min at 48C, reduced glutathione (GSH) and oxidized glutathione (GSSG) in the supernatant were determined by using an HPLC-electrochemical detection method with potentials applied from 60 to 960 mV at 60-mV increments (28) . Concentrations of GSH and GSSG were calculated on the basis of calibration curves of authentic GSH and GSSG. Total GSH was calculated as GSH + 23 GSSG, and the ratio of GSH/GSSG was determined.
Statistical analysis. Results are expressed as means 6 SEM. Statistical analysis was performed by using a SYSTAT statistical package (SYSTAT 12, 2007; Systat Software). Significant differences were determined by ANOVA for overall effects of diet and p.i. time. Repeated-measures ANOVA was used for body weight data because these data were collected for the same animals that were killed on d 9 p.i. Two-way ANOVA was used for all of the other data. A logarithmic transformation was applied to the data prior to formal analysis to reduce heterogeneity. In addition, a MIXED procedure in SAS (SAS Institute, Inc.) was used to fit a 2-way ANOVA model with heterogeneous variances. Correlation analysis was conducted by using Pearson's correlation test. Significance was set at P , 0.05.
Results
Supplementation with LWB prevented body weight loss caused by influenza infection. All of the mice gradually gained weight during the feeding period to the extent that is usually observed in mice at this age. LWB supplementation had no effect on weight gain prior to infection (data not shown). Weight loss is a main symptom of illness severity in influenzainfected mice. An overall significant p.i. time (P , 0.001) and diet (P , 0.05) effect for the weight loss was detected by ANOVA, indicating that all mice lost weight in response to infection, and that mice fed LWB lost significantly less weight compared with those fed the control diet (Fig. 1) .
LWB supplementation did not affect lung viral titer. The viral titers in lungs were measured at d 2, 6, and 9 p.i. No viral titer was detected in uninfected mice (time 0). There was no significant overall p.i. time effect or diet effect detected by ANOVA in viral titer of infected mice.
LWB supplementation reduced lung pathology caused by influenza infection. Pathologic change, measured by infiltration of inflammatory cells to the lung, was examined at d 0, 6, and 9 p.i. There was an overall diet effect by ANOVA, indicating that mice fed LWB had significantly lower lung pathology scores than did those fed the control diet (Fig. 2) .
Effect of LWB supplementation on lymphocyte proliferation. Splenocytes isolated from mice at each of the p.i. time points were stimulated with con A, phytohemagglutinin P, or anti-CD3 to determine T cell proliferative responses. ANOVA indicated that there was no overall p.i. time or diet effect on T cell proliferation (data not shown).
NK cell activity. NK activity in both lung and spleen cells was examined at d 0 and 2 p.i. Influenza infection induced higher NK activity. LWB supplementation did not affect NK activity in either spleen or lung cells, under infected or uninfected conditions (data not shown).
Cytokine production in spleen cells. Th1 cytokines IFNg and IL-2 and Th2 cytokine IL-10 are known to be involved in defense against viral infection. ANOVA showed an overall p.i. time effect for IFNg (P , 0.05) and IL-10 production (P , 0.05) and an overall diet effect for IL-2 production (P , 0.05) ( Table 1) , which suggests an infection-induced upregulation in IFNg and IL-10 production and an LWB-induced improvement in IL-2 production, respectively.
Effect of LWB on production of proinflammatory cytokines in lung and spleen. Infection can induce proinflammatory cytokines. Proinflammatory cytokines can help activate immune cells to fight pathogens; however, this induced inflammation often causes tissue damage and leads to severe clinical symptoms. We measured the production of IL-1b, IL-6, and TNFa under 2 conditions: infection-induced local production in lung and ex vivo-induced production in spleen cells after stimulation with LPS. In the lung, influenza infection significantly upregu- lated production of TNFa, IL-1b, and IL-6 as indicated by an overall p.i. time effect for all of these cytokines by ANOVA (all at P , 0.0001); LWB supplementation had no overall effect on production of these cytokines, and there was no diet 3 time interaction ( Table 2 ). In spleen, although neither infection nor diet affected LPS-stimulated TNFa and IL-6 production, there was an overall p.i. time effect for IL-1b production by ANOVA (P , 0.05) ( Table 2) .
Immune cell phenotype in spleen. Neither viral infection nor LWB supplementation affected the percentage of total T cells, CD4 + T cells, CD8 + T cells, and their naive or memory subsets in spleen (data not shown).
Weight loss and pathology score correlate with viral titer. In mice, weight loss and subsequent recovery are markers for monitoring the severity and progress of illness after influenza infection. Lung viral titer and pathology scores are usually positively correlated with the severity of disease. In this study, we found positive correlations between lung viral titer, weight loss, and pathology ( Table 3 ). Given that viral infection induces production of proinflammatory cytokines, which play a role in both viral infection-induced tissue damage and systemic symptoms, we analyzed the correlation between proinflammatory cytokines and severity of influenza infection as indicated by weight loss. The results showed that weight loss was positively correlated with each of the proinflammatory mediators (Table 3) .
LWB-induced alleviation of severity of influenza infection
is associated with enhancement of T cell proliferation and IL-2 production. T cell-mediated immune response plays a key role in controlling influenza infection; therefore, we evaluated the correlation between weight loss and T cell proliferation as well as weight loss and T cell growth factor IL-2. There was a negative correlation between IL-2 or lymphocyte proliferation and weight loss. Furthermore, as expected, there was also a significant correlation between IL-2 and T cell proliferation (Table 3) . No correlation between viral titer or disease severity and other cytokines was observed. These results suggest that LWB may have a beneficial effect on resistance to influenza infection, due in part to decreasing proinflammatory mediators and/or enhancing T cell-mediated function.
GSH and GSSG levels in liver. Because infection is known to be associated with increased oxidative stress and because wolfberries contain antioxidant phytochemicals, we wished to know if the observed beneficial effect of LWB on influenza infection might be related to antioxidant activity. Results showed that infection significantly reduced the levels of both reduced-form and total GSH in the supernatant of homogenized liver as indicated by an overall p.i. time effect by ANOVA (P , 0.05), but it had no effect on GSSG or GSH:GSSG ratio (data not shown). On d 9 p.i., GSH concentrations returned to levels similar to those seen in uninfected mice (data not shown). We did not observe any effect of LWB on GSH, GSSG, or GSH:GSSG ratio (data not shown). Thus, it does not seem likely that LWB's effect on viral infection is mediated through modulation of redox balance.
Discussion
Although the health benefits of wolfberry have been proposed for a long time (8) (9) (10) 29) , supporting scientific evidence is still limited. Wolfberry supplementation was shown to increase the number of lymphocytes and levels of IL-2 and IgG compared with the placebo group in a human study (20) and to enhance humoral and cell-mediated immune responses after antigenic challenge in mice (19) . Wolfberry polysaccharides-protein complex can induce phenotypic and functional maturation of dendritic cells (30) , which enhance T helper cell response (31) and upregulate cytokine expression in human peripheral blood mononuclear cells (9) . These results suggest that the immuno- 1 Values are means 6 SEM; n = 8-10 /group for lung, n = 6-8 /group for spleen. Data were log-transformed prior to statistical analysis, and the MIXED procedure in SAS (SAS Institute) was used to fit 2-way ANOVA with heterogeneous variances; backtransformed data are presented in the modulating effect of wolfberry might potentially enhance the host's defense against microbial infection; however, the scientific evidence in this regard is lacking. To test our theory, we used the influenza virus A infection mouse model to determine whether dietary supplementation with LWB can enhance the host's resistance to viral infection by modulating the host's immune response. In this study, 2 primary outcomes were evaluated upon infection: clinical symptoms and quantitative virology. The clinical signs of influenza infection in mice include loss of appetite, weight loss, hunched posture, ruffled fur (piloerection), neurologic symptoms (hind-limb paralysis), and death. Weight loss is the primary objective indicator of infection severity for monitoring the disease's progress. We used the levels of viral load combined with histopathologic analysis and weight loss to determine the impact of LWB on viral infectivity and pathogenesis. To further determine the mechanism underlying the antiviral effect of wolfberry, we evaluated immune cell phenotype and function. Although we did not observe a difference in viral titer between mice fed LWB and those fed the control diet, we did observe an effect of LWB on weight loss and pathology, which are 2 indicators of the severity of influenza infection. In addition, the effects of LWB on weight reduction and pathology were correlated with the level of lung viral infectivity. Although viral titers have been shown to be positively related to the severity of symptoms including weight loss, disagreement between the 2 outcomes was also reported in previous studies, indicating that the viral titer does not always reflect the severity of infection in the host (32) . Taken together, these data suggest a beneficial effect of LWB on severity of influenza infection and thus the clinical outcome, despite the lack of an effect on viral titers.
Influenza virus infects the respiratory tract, and the most severe complication is primary viral pneumonia. During infection with influenza, an appropriate coordination of both innate and adaptive immune response is necessary for the host to clear the virus and recover from the infection. Because NK cells play a critical role in the early phase of infection, we measured NK cells activity only on d 0 (uninfected) and on d 2 p.i. We found that influenza infection induced a higher NK activity but LWB supplementation had no effect on NK activity. This might explain the lack of a significant effect of LWB on viral titer on d 2 p.i. During infection, dendritic cells, macrophages, and lung epithelial cells upregulate the expression of cytokines and chemokines in a coordinated and specific cascade (33, 34) . Antiviral and proinflammatory cytokines are induced first, IL-6 expression follows, and finally chemokines are expressed (35) . These molecules play a key role in the early inhibition of viral replication (36) , the stimulation of inflammatory response (37), mediation of acute pulmonary inflammatory pathology (38) , and recruitment of immune cells to the infection site (39) . As expected, influenza infection in this study induced lung inflammation as indicated by significant upregulation of 3 proinflammatory cytokines (TNFa, IL-1b, and IL-6) in lung. It has been noted that proinflammatory cytokines have a dual role in host response to microbial pathogen infection. On the one hand, proinflammatory cytokines can facilitate T cell activation and proliferation to control pathogens (40) . On the other hand, they can mediate tissue inflammatory pathology and contribute to the pathogenesis of disease (41, 42) . Increasing evidence has shown that the inflammatory response to influenza infection plays a key role in the disease's pathogenesis, but it makes a modest contribution toward preventing viral infectivity (41, 42) . For example, depletion of the inflammatory cytokine TNFa reduces recruitment of inflammatory cells to the lung and the severity of disease without affecting virus clearance upon secondary infection with respiratory syncytial virus or influenza virus (43) . IL1a/b mediates acute pulmonary inflammatory pathology while having little effect on the clearance of influenza virus (38) . In this study, we observed that LWB supplementation reduced weight loss and pathology. Although there was no overall significant effect of diet on proinflammatory cytokines in lung, animals fed the control diet had numerically higher production of all 3 proinflammatory cytokines on d 6 p.i. compared with animals fed LWB: by 144% (P = 0.07) for IL-6, by 62% (P = 0.07) for TNFa, and by 28% (P = 0.27) for IL-1b, respectively. All of these proinflammatory cytokines are known to be positively correlated to infection-induced pathology and symptoms including weight loss (44) (45) (46) . Therefore, these data, although statistically not significant, when taken together with the observed highly significant positive correlation between weight loss and pathology with each of these proinflammatory cytokines suggest that the LWB-induced reduction in weight loss and pathology may be mediated, at least in part, through modulation of proinflammatory cytokines.
It has been reported that dietary supplementation with LWB enhances in vivo humoral and cell-mediated immune responses after antigenic challenge (19) . Although CD8 + cytotoxic activity is crucial for the clearance of influenza virus, Th1 CD4 + T cells also play an important role in the protection against and recovery from influenza infection (47, 48) .To further understand the underlying mechanisms of LWB's effect, we investigated whether LWB also positively affects T cell-mediated immunity under the conditions of infection. We found that LWB supplementation enhanced con A-stimulated IL-2 production after infection. Given the critical role of IL-2 in T cell expansion and T cell-mediated immune response to infection, it is not surprising to see a significant, negative correlation between weight loss and T cell proliferation or IL-2 production, which suggests that the protective effect of LWB in influenza infection may in part be due to the enhanced T cell function.
Influenza infection has been shown to reduce antioxidant status in the lungs of mice (49) . Because LWB contains antioxidant compounds (0.73 mg/g of zeaxanthin, 5 mg/g of vitamin C precursor) (50), we wanted to learn whether this could be a contributing factor to the improved immune response and resistance to the infection observed in our study. Thus, we determined whether LWB had an impact on redox status of the host. As expected, we found that influenza infection resulted in a decrease in tissue levels of total and reduced GSH. However, LWB had no effect on tissue GSH levels in either uninfected or infected mice. These data suggest that the antioxidants delivered by LWB are too low to affect redox status under the current experimental condition and LWB's enhancement of T cell function is not likely to be mediated through a change in antioxidant status.
In this study we fed mice 5% LWB, a dose that could have clinical relevance and translational value as indicated below. LWB used in this study contained ;50% wolfberry, and thus 5% LWB is equivalent to 2.5% wolfberry. A mouse consumes ;3 g/d of diet, which translates into a daily consumption of wolfberry at 5 g/kg body weight for a mouse weighing 30 g. When this dose is converted from mice consuming 12 kJ/d to humans consuming 2000 kJ/d, using isocaloric calculation (51, 52) , it is equivalent to 0.18 g/kg body weight in humans, or 12.6 g/d consumed by a person weighing 70 kg. A recent study showed that the elderly subjects (aged 65-70 y) receiving 13.7 g/d of LWB for 3 mo had improved macular characteristics compared with the placebo group (50). Thus, the dose used in the current study is both feasible to be consumed by humans and could have translational potential.
In summary, we have shown that dietary supplementation with LWB has a beneficial effect in reducing the severity of influenza infection. Furthermore, our data suggest that this effect of LWB may be due to its enhancement of T cell function and/or reduction in proinflammatory cytokines. Future studies will further determine the underlying mechanisms of LWB's effects on viral infection and immune functions as well as its potential application in humans.
